3DT Holdings, LLC (Drugs and Devices for Diagnostics and Therapeutics – “3DT”) was created to stimulate the establishment and growth of technology based start – up companies, specifically in the areas of cardiovascular and obesity-related diseases and disorders. By fulfilling this mission, 3DT will contribute to discovery of new and useful devices and therapeutics in the treatment of human disease conditions.

3DT provides new and emerging medical device technology businesses with an environment that supports their start-up phase and increases their likely hood of success. 3DT offers facility space, shared use of common office equipment, direct business assistance and guidance, mentoring, networking to capital, and other technical resources.